Clinical Trials Logo

Oncology clinical trials

View clinical trials related to Oncology.

Filter by:

NCT ID: NCT04624165 Completed - Oncology Clinical Trials

Patient Perspective of Telemedicine in Gynecology Oncology

Start date: January 21, 2021
Phase:
Study type: Observational

Research question: do patients in a gynecologic oncology practice value the use of telemedicine as an adjunct to in-person visits and in what circumstances might patients not find these visits to be sufficient?

NCT ID: NCT04623437 Completed - Oncology Clinical Trials

Responsible Side Effects Management in Oncology

R-SEMO
Start date: July 1, 2017
Phase:
Study type: Observational

Study of pharmacovigilance in oncology. Monitoring and management of AEs during antineoplastic treatment.

NCT ID: NCT04615156 Not yet recruiting - Oncology Clinical Trials

18F-2-fluoro-2-deoxy-D-glucose in Positron Emission Tomography Computed Tomography

Start date: November 1, 2020
Phase: Phase 3
Study type: Interventional

The study objectives are as follows: - To determine the safety of trial 18F-2-fluoro-2-deoxy-D-glucose, produced by a new manufacturer, by surveillance for adverse events in patients having Positron Emission Tomography Computed Tomography scans in a comprehensive program for indications including, but not limited to, oncology, neurology, cardiac and infectious/inflammatory processes. - To determine the efficacy of 18F-2-fluoro-2-deoxy-D-glucose Positron Emission Tomography in differentiating benign from malignant solitary pulmonary nodules and calculate sensitivity, specificity, and accuracy using pathologic confirmation as the gold standard when available, or greater than 6 month follow up stability on Computed Tomography scan when not. The purpose of performing this clinical trial is to provide local access of 18F-2-fluoro-2-deoxy-D-glucose to the patients of Newfoundland and Labrador. This product has been offered to patients over the last three years by transporting from facilities outside of the province. There have been significant delays in access and in fact, times where 18F-2-fluoro-2-deoxy-D-glucose has not been available through this process. This has caused delays and limitations of treatments for patients who rely on Positron Emission Tomography Computed Tomography scans for diagnosis.

NCT ID: NCT04544540 Not yet recruiting - Anemia Clinical Trials

One Versus Two Unit Transfusions in Oncology Patients - The OTTOP Trial: A Randomized Open-label Pragmatic Controlled Trial

OTTOP
Start date: November 1, 2020
Phase: N/A
Study type: Interventional

The aim of this trial is to determine if the transfusion of one unit of red blood cells to anemic oncology patients results in comparable numbers of transfusion episodes when compared to transfusion of two units of red blood cells.

NCT ID: NCT04543045 Recruiting - Anxiety Clinical Trials

Qualitative Exploration of Head & Neck Cancer Patient Reported Experience of Radiotherapy

H&NPRER-RAC
Start date: May 5, 2021
Phase:
Study type: Observational

The study aims to explore the experience of patients with Head and Neck Cancer, who are preparing for and/or completed radiotherapy treatment.

NCT ID: NCT04517773 Not yet recruiting - Oncology Clinical Trials

"Patient Autonomie" in People With Cancer

AUPAC
Start date: December 2020
Phase:
Study type: Observational

In France, the notion of autonomy concerning the patient's place in the healthcare system has been written into legal texts for several years. This notion is also fully recognized in our society and in the medical field by caregivers. However, the notion of autonomy is polysemous and complex. There is no unambiguous definition given the existence of plural conceptions of autonomy, especially in the field of psychology. A precedent thesis on the "representation of the autonomous patient in decision-making in the context of recurrence". Physicians practicing in oncology have been asked to perform a verbal association task inviting them to evoke the 5 words or expressions that came to their mind following the inductive word "autonomous patient". The results shows that for doctors, the "autonomous patient" is a patient with all of his physical, motor and intellectual capacities. Based on these findings, it would be interesting to study the autonomy perceived by the patient himself.

NCT ID: NCT04495790 Recruiting - Neoplasms Clinical Trials

AIMS Cancer Outcomes Study

ACOS
Start date: May 18, 2020
Phase:
Study type: Observational [Patient Registry]

The overall aim is to describe disease-free survival (DFS) in early stage cancer patients and three-year overall survival (OS) outcomes in advanced stage cancer patients receiving Advanced Integrative Oncology (AIO) treatment in a prospective consecutive case series outcomes study. We will collect data and study outcomes for patients with cancer who receive care at AIMS Institute.

NCT ID: NCT04488549 Completed - Surgery Clinical Trials

Delayed Colorectal Cancer Care During Coronavirus Disease (COVID-19) Pandemic (DECOR-19)

DECOR-19
Start date: May 20, 2020
Phase:
Study type: Observational

To understand and analyse the global impact of COVID-19 on outpatient services, inpatient care, elective surgery, and perioperative colorectal cancer care, a DElayed COloRectal cancer surgery (DECOR-19) survey was conducted in collaboration with numerous international colorectal societies with the objective of obtaining several learning points from the impact of the COVID-19 outbreak on our colorectal cancer patients which will assist us in the ongoing management of our colorectal cancer patients and to provide us safe oncological pathways for future outbreaks.

NCT ID: NCT04464486 Completed - Oncology Clinical Trials

Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic

Start date: April 21, 2020
Phase: N/A
Study type: Interventional

This project will evaluate the benefit of an automated home symptom monitoring system, Symptom Care at Home, to track COVID-19 symptoms, provide instructions to reduce COVID-19 exposure, and reduce cancer symptom severity during the COVID-19 pandemic. The investigators will determine if Symptom Care at Home decreases the need for cancer patients to use emergency departments and hospitalization for cancer symptom care. The project addresses the urgent public health need for cancer patients to reduce their risk for COVID-19 exposure.

NCT ID: NCT04461392 Not yet recruiting - Oncology Clinical Trials

Exercise Response After Revalidation in Cancer Patients

Start date: August 2020
Phase: N/A
Study type: Interventional

This study regarding oncological patients for rehabilitation after specific cancer therapy involves three aims: (1) to evaluate the predictive value of myocardial work parameters on the improvement of exercise performance after rehabilitation, (2) to determine which echocardiographic parameters are more suitable in predicting cardiac dysfunction, and (3) to evaluate the correlation between echocardiographic parameters and fibrosis detected by cardiac magnetic resonance imaging (CMR).